UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 105

Sortiert nach

Resection of colorectal cancer (CRC) metastases in routine practice

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.599-599

2014

Link zum Volltext

Verfügbarkeit prüfen

PTEN hamartoma tumor syndrome (PHTS): Clinical characteristics, onco-phenotype, and molecular analysis

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1510-1510

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of anti-VEGF therapy in metastatic colorectal cancer with an intact primary tumour

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.650-650

2016

Link zum Volltext

Verfügbarkeit prüfen

Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.617-617

2016

Link zum Volltext

Verfügbarkeit prüfen

Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.563-563

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8533-8533

2014

Link zum Volltext

Verfügbarkeit prüfen

TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2- proficient triple-negative breast cancer (TNBC)—Evaluating the homologous recombination deficiency (HRD) biomarker

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS1145-TPS1145

2014

Link zum Volltext

Verfügbarkeit prüfen

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8523-8523

2015

Link zum Volltext

Verfügbarkeit prüfen

Spectrum of colon polyposis and colonic neoplasia in the PTEN hamartoma tumor syndrome (PHTS)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3627-3627

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase lb study of oral panobinostat and IV bortezomib in relapsed or relapsed and refractory multiple myeloma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8075-8075

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients (pts) with recurrent ovarian carcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5000-5000

2010

Link zum Volltext

Verfügbarkeit prüfen

Changes in Medicaid reimbursements for cancer screening: Keeping pace with inflation?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6043-6043

2011

Link zum Volltext

Verfügbarkeit prüfen

Third-line salvage chemotherapy for recurrent cervical cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15510-e15510

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of TH-302, an investigational hypoxia-targeted drug, and dexamethasone in patients with relapsed/refractory multiple myeloma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8602-8602

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical response by baseline characteristics in patients (pts) with relapsed and bortezomib (BTZ)-refractory multiple myeloma treated with panobinostat (PAN), BTZ, and dexamethasone (DEX; PANORAMA 2)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8531-8531

2013

Link zum Volltext

Verfügbarkeit prüfen

The correlation of cone biopsy with findings at radical hysterectomy and the need for adjuvant radiation therapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5122-5122

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of tumor site on bevacizumab (BEV) efficacy in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14558-e14558

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10065-10065

2014

Link zum Volltext

Verfügbarkeit prüfen

Preliminary safety and efficacy of TH-302, an investigational hypoxia-targeted drug, and dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RR MM)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8534-8534

2014

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care capture of clinical interventions for metastatic colorectal cancer (mCRC) to develop and validate novel markers of the quality of cancer care

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e17637-e17637

2014

Link zum Volltext

Verfügbarkeit prüfen

Expression of angiopoietin (Ang) pathway markers and their relationship to progression-free survival (PFS) in TRINOVA-1

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5542-5542

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of clinicopathologic features in metastatic rectal versus colon cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14518-e14518

2014

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of the predictive and prognostic value of erlotinib-related biomarkers in phase III, placebo-controlled trials in non-small cell lung cancer (NSCLC): Recommendations of the BioLOGUE advisors

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7533-7533

2011

Link zum Volltext

Verfügbarkeit prüfen

PANORAMA 2: A phase II study of panobinostat (LBH589) in combination with bortezomib (BTZ) and dexamethasone (DEX) in patients with relapsed and BTZ-refractory multiple myeloma (MM)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS308-TPS308

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of denileukin diftitox (Dd) in cutaneous T-cell lymphoma (CTCL) patients: Integrated analysis of three large phase III trials

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8551-8551

2008

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 105

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(105)

Sprache

Englisch
(105)
Japanisch
(2)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Resection of colorectal cancer (CRC) metastases in routine practice

PTEN hamartoma tumor syndrome (PHTS): Clinical characteristics, onco-phenotype, and molecular analysis

Impact of anti-VEGF therapy in metastatic colorectal cancer with an intact primary tumour

Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry

Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma

TBCRC030: A randomized, phase II study of preoperative cisplatin versus paclitaxel in patients (pts) with BRCA1/2- proficient triple-negative breast cancer (TNBC)—Evaluating the homologous recombination deficiency (HRD) biomarker

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM)

Spectrum of colon polyposis and colonic neoplasia in the PTEN hamartoma tumor syndrome (PHTS)

A phase lb study of oral panobinostat and IV bortezomib in relapsed or relapsed and refractory multiple myeloma

Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients (pts) with recurrent ovarian carcinoma

Changes in Medicaid reimbursements for cancer screening: Keeping pace with inflation?

Third-line salvage chemotherapy for recurrent cervical cancer

Phase I study of TH-302, an investigational hypoxia-targeted drug, and dexamethasone in patients with relapsed/refractory multiple myeloma

Clinical response by baseline characteristics in patients (pts) with relapsed and bortezomib (BTZ)-refractory multiple myeloma treated with panobinostat (PAN), BTZ, and dexamethasone (DEX; PANORAMA 2)

The correlation of cone biopsy with findings at radical hysterectomy and the need for adjuvant radiation therapy

Impact of tumor site on bevacizumab (BEV) efficacy in metastatic colorectal cancer (mCRC)

A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report

Preliminary safety and efficacy of TH-302, an investigational hypoxia-targeted drug, and dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RR MM)

Point-of-care capture of clinical interventions for metastatic colorectal cancer (mCRC) to develop and validate novel markers of the quality of cancer care

Expression of angiopoietin (Ang) pathway markers and their relationship to progression-free survival (PFS) in TRINOVA-1

Prognostic impact of clinicopathologic features in metastatic rectal versus colon cancer

Meta-analysis of the predictive and prognostic value of erlotinib-related biomarkers in phase III, placebo-controlled trials in non-small cell lung cancer (NSCLC): Recommendations of the BioLOGUE advisors

PANORAMA 2: A phase II study of panobinostat (LBH589) in combination with bortezomib (BTZ) and dexamethasone (DEX) in patients with relapsed and BTZ-refractory multiple myeloma (MM)

Efficacy and safety of denileukin diftitox (Dd) in cutaneous T-cell lymphoma (CTCL) patients: Integrated analysis of three large phase III trials

Aktive Filter

Suchergebnisse filtern